Mohammed Alharbi

King Saud bin Abdulaziz University for Health Sciences

Papers

Total Citations

H-Index

About

Mohammed Alharbi is a prominent researcher in urologic oncology, with a focused expertise in the surgical management of kidney cancer. His work critically addresses the rising incidence of renal malignancies, particularly within the Saudi Arabian population, where rates have surged by 33%. Alharbi’s major contribution lies in advancing the understanding and application of partial nephrectomy (PN), which he has established as the gold-standard treatment for T1 renal masses. Through his highly cited 2021 study, "Partial Nephrectomy: A Comparison between Different Modalities," he provides a comprehensive analysis of surgical techniques, offering crucial guidance for optimizing patient outcomes. This work, which has garnered 7 citations, is a key resource for clinicians navigating the complexities of nephron-sparing surgery. By comparing various PN modalities, Alharbi has helped refine surgical protocols and improve the evidence base for treating kidney cancer, a disease that comprises 4% of all adult malignancies. His research is instrumental in shaping modern urologic practice, particularly in regions facing a growing cancer burden, and underscores his commitment to enhancing surgical precision and patient survival.